Nuclear Medicine
FDG
Name:
18F FDG Radiofarma®
Active Principle:
Deoxiglucose Fluor
Therapeutic Action:
It is indicated for the measurement of glucose metabolism, the diagnosis of primary, recurrent or metastatic disease of various tumors and for the study of cardiomyopathies, osteoarthropathies and neurological lesions.
Nuclear Medicine
FDG
Name:
18F FDG Radiofarma®
Active Principle:
Deoxiglucose Fluor
Therapeutic Action:
It is indicated for the measurement of glucose metabolism, the diagnosis of primary, recurrent or metastatic disease of various tumors and for the study of cardiomyopathies, osteoarthropathies and neurological lesions.
